Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B. Johnson, Justin M. Balko, Ann Richmond et al.|Nature Communications|2016Cited by 572
The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐upMelinda E. Sanders, David L. Page, Peggy A. Schuyler et al.|Cancer|2005Cited by 485
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian CarcinomaYingwei Hu, Melinda E. Sanders, Jianbo Pan et al.|Cell Reports|2020Cited by 155
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasisSusana García‐Recio, Lisa A. Carey, Toshinori Hinoue et al.|Nature Cancer|2022Cited by 114
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancerMaria Vittoria Dieci, Valentina Guarneri, PierFranco Conte et al.|Annals of Oncology|2019Cited by 96